Medicare Procedure and Patient Information
2015 Medicare Procedure Volume
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 16 |
|---|
(No ratings)
Dr. Bardia Nourbakhsh, MD is a null in Bethesda, MD specializing in psychiatry & neurology and general practice. Dr. Bardia Nourbakhsh, MD is affiliated with The Johns Hopkins Hospital.
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2024, Dr. Bardia Nourbakhsh, MD had a list price for ophthalmic (eye and orbit) imaging that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Maryland. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
In 2012, Dr. Bardia Nourbakhsh, MD had a list price for eye tests that was lower than the list prices billed to Medicare by 75% of providers in related specialties within Maryland. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 16 |
|---|
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 15 |
|---|
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 52 |
|---|
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 11 |
|---|---|
| Female | 35 |
| Non-Hispanic White | 33 |
|---|---|
| Black | 13 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 23 |
| Hypertension | 46 |
|---|---|
| High Cholesterol | 41 |
| Stroke | 0 |
| Ischemic Heart Disease | 24 |
| Depression | 37 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 24 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 51 |
|---|
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 11 |
|---|---|
| Female | 44 |
| Non-Hispanic White | 36 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 24 |
| Hypertension | 45 |
|---|---|
| High Cholesterol | 45 |
| Stroke | 0 |
| Ischemic Heart Disease | 27 |
| Depression | 35 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 73 |
|---|
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 22 |
|---|---|
| Female | 54 |
| Non-Hispanic White | 54 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 24 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 41 |
| Hypertension | 42 |
|---|---|
| High Cholesterol | 41 |
| Stroke | 0 |
| Ischemic Heart Disease | 21 |
| Depression | 39 |
| Chronic Kidney Disease | 22 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 20 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 53 |
|---|
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Non-Hispanic White | 37 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 25 |
| Hypertension | 46 |
|---|---|
| High Cholesterol | 50 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 38 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 85 |
|---|
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 18 |
|---|---|
| Female | 59 |
| Non-Hispanic White | 50 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 37 |
| Hypertension | 36 |
|---|---|
| High Cholesterol | 42 |
| Stroke | 0 |
| Ischemic Heart Disease | 14 |
| Depression | 40 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 16 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 21 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 69 |
|---|
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 22 |
|---|---|
| Female | 56 |
| Non-Hispanic White | 42 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 41 |
| Hypertension | 62 |
|---|---|
| High Cholesterol | 51 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 37 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 23 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 21 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 60 |
|---|
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 15 |
|---|---|
| Female | 37 |
| Non-Hispanic White | 34 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 26 |
| Hypertension | 54 |
|---|---|
| High Cholesterol | 56 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 31 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 23 |
| Dementia | 0 |
| Cancer | 0 |
The top procedures that Dr. Bardia Nourbakhsh, MD treated as a null in Bethesda, MD during 2024 were eye procedures.
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
| doctor visit | 59 |
|---|---|
| eye procedures | 11 |
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 15 |
|---|---|
| Female | 43 |
| Non-Hispanic White | 38 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 29 |
| Hypertension | 60 |
|---|---|
| High Cholesterol | 57 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 34 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 19 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Bardia Nourbakhsh, MD for Medicare patients.
The highest averages for the top procedures that Dr. Bardia Nourbakhsh, MD treated as a null in Bethesda, MD were eye procedures.
| doctor visit | 53 |
|---|---|
| eye procedures | 11 |
Information about Medicare patients treated by Dr. Bardia Nourbakhsh, MD.
| Male | 11 |
|---|---|
| Female | 32 |
| Black / African American | 1 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 32 |
| Hispanic | 0 |
| Native American / Alaskan Native | 0 |
| Other | 0 |
| 75 to 84 | 0 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 24 |
| 65 to 74 | 2 |
The highest averages of the most common conditions of Medicare patients that Dr. Bardia Nourbakhsh, MD treated were hypertension, high cholesterol, depression and diabetes.
| Hypertension | 39 |
|---|---|
| High Cholesterol | 38 |
| Stroke | 0 |
| Ischemic Heart Disease | 8 |
| Depression | 29 |
| Chronic Kidney Disease | 2 |
| Asthma | 0 |
| Osteoporosis | 5 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 10 |
| Atrial Fibrillation | 0 |
| Cancer | 0 |
| Dementia | 0 |
He has a state license in California.
Licensed In: California
Dr. Bardia Nourbakhsh, MD does not have any reviews yet, be the first to leave a review of Dr. Bardia Nourbakhsh, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Bardia Nourbakhsh, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Jazz Pharmaceuticals Inc. |
$9,000
$9,000 |
|||||
|---|---|---|---|---|---|---|
| Alkermes, Inc. |
$1,500
$1,500 |
|||||
| GENZYME CORPORATION |
$480
DISEASE STATE $249 |
AUBAGIO $90 |
LEMTRADA $80 |
MS DISEASE STATE $52 |
NO PRODUCT DISCUSSED $4 |
Other $4 |
| Genentech USA, Inc. |
$359
Ocrevus Zunovo $269 |
OCREVUS $90 |
||||
| Biogen, Inc. |
$192
TECFIDERA $63 |
PLEGRIDY $12 |
$118 |
|||
| Other |
$448
Gilenya $190 |
PLEGRIDY $102 |
OCREVUS $64 |
UPLIZNA $53 |
Ocrevus Zunovo $27 |
Other $12 |
| Consulting Fee | $10,500 |
|---|---|
| Food and Beverage | $1,466 |
| Education | $13 |
Dr. Bardia Nourbakhsh, MD has received 19 research payments totaling $1,089,406.
Bardia Nourbakhsh, M.D., M.A.S., is an associate professor of neurology at Johns Hopkins University School of Medicine. He practices out of The Johns Hopkins Hospital in Baltimore, Maryland.Dr. Nourbakhsh has expertise in multiple sclerosis (MS) and neuroimmunology.Dr. Nourbakhsh earned his medical degree from the Tehran University School of Medical Sciences and completed a residency in neurology at the University of Texas Southwestern Medical Center. He studied epidemiology, study design, and biostatistics, obtaining a Master of Advanced Studies degree in clinical research from the University of California, San Francisco School of Medicine, where he also completed a fellowship in MS and neuroimmunology.In 2014, Dr. Nourbakhsh earned the American Brain Foundation Clinical Research Training Fellowship in MS, the National Multiple Sclerosis Society Sylvia Lawry Clinical Research Fellowship, the Fred Baskin Young Investigator Award, and the Teva Neuroscience Award for Academic Excellence.In 2022, he was named a Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis Society.Dr. Nourbakhsh's research training focused on the design and execution of clinical trials and the use of biomarkers in MS. His current research interests include the comparative effectiveness studies of symptomatic and disease-modifying therapies in MS, as well as identifying new pathophysiologic mechanisms and therapeutic targets for MS-related fatigue. Dr. Nourbakhsh is the principal investigator of a randomized, double-blind clinical trial funded by the Department of Defense, which tests whether ketamine could be a treatment for MS fatigue. He has contributed to numerous publications, journal articles, abstracts and posters, and lectures. He is an ad hoc reviewer for Lancet Neurology, Annals of Neurology, Neurology, Neurology: Neuroimmunology and Neuroinflammation, Multiple Sclerosis Journal, and other journals.